𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The effects of recombinant human granulocyte-macrophage colony-stimulating factor on the induction of lymphokine-activated killer cells in vitro

✍ Scribed by Seiichi Okamura; Tanaka Takeshi; Shigeru Yamaga; Fusayuki Omori; Niho Yoshiyuki

Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
544 KB
Volume
13
Category
Article
ISSN
0192-0561

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pilot study of recombinant human granulo
Pilot study of recombinant human granulocyte-macrophage colony–stimulating factor in the treatment of chronic hepatitis B
✍ Julio Martin; Orencio Bosch; Gloria Moraleda; Javier Bartolome; Juan Antonio Qui πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 593 KB

is a fellow of Ministerio de Educaci6n y Ciencia. J. Bartolome and J.A. Quiroga are recipients of research grants from Fundacion para el Estudio de las Hepatitis Vudes.

Treatment of de novo acute myelogenous l
Treatment of de novo acute myelogenous leukemia with recombinant granulocyte macrophage-colony-stimulating factor in combination with standard induction chemotherapy: Effect of granulocyte macrophage-colony-stimulating factor on white blood cell counts
✍ Valent, Peter ;Sillaber, Christian ;Geissler, Klaus ;Andreeff, Michael ;Tafuri, πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 418 KB

GM-CSF is a major regulator of myelopoiesis. Recombinant human GM-CSF (250 micrograms/m2 per day i.v.) was used prior to chemotherapy ("3 + 7" scheme) to recruit leukemic blasts in vivo (de novo AML patients, n = 20) into the chemotherapy sensitive phases of the cell cycle. The stimulatory effect of